Michael Greiner

610 total citations
9 papers, 123 citations indexed

About

Michael Greiner is a scholar working on Infectious Diseases, Epidemiology and Transplantation. According to data from OpenAlex, Michael Greiner has authored 9 papers receiving a total of 123 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Infectious Diseases, 4 papers in Epidemiology and 2 papers in Transplantation. Recurrent topics in Michael Greiner's work include Cytomegalovirus and herpesvirus research (3 papers), Neurological Complications and Syndromes (2 papers) and Renal Transplantation Outcomes and Treatments (2 papers). Michael Greiner is often cited by papers focused on Cytomegalovirus and herpesvirus research (3 papers), Neurological Complications and Syndromes (2 papers) and Renal Transplantation Outcomes and Treatments (2 papers). Michael Greiner collaborates with scholars based in Switzerland. Michael Greiner's co-authors include Nicolas J. Mueller, Andrea Zbinden, Peter M. Keller, Michael Huber, Osvaldo Zagordi, Alexandra Trkola, Peter W. Schreiber, Riccarda Capaul, Jürg Böni and Bruno Ledergerber and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and Journal of Antimicrobial Chemotherapy.

In The Last Decade

Michael Greiner

7 papers receiving 122 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Greiner Switzerland 6 61 37 27 20 18 9 123
Zhiqiang Zhuo China 7 65 1.1× 47 1.3× 46 1.7× 17 0.8× 12 0.7× 25 158
Alicia B. Mitchell Australia 9 69 1.1× 39 1.1× 72 2.7× 41 2.0× 22 1.2× 15 161
Mélanie Fromentin France 6 36 0.6× 21 0.6× 30 1.1× 40 2.0× 23 1.3× 9 139
Liliana A González Chile 7 95 1.6× 21 0.6× 33 1.2× 24 1.2× 57 3.2× 9 176
Jelena Hubrechts Belgium 7 57 0.9× 45 1.2× 14 0.5× 13 0.7× 17 0.9× 22 126
Martin Vavřina Czechia 7 87 1.4× 22 0.6× 15 0.6× 20 1.0× 14 0.8× 9 174
Paul R Allyn United States 5 54 0.9× 52 1.4× 14 0.5× 4 0.2× 24 1.3× 8 88
G Cazzola Italy 9 47 0.8× 13 0.4× 54 2.0× 25 1.3× 28 1.6× 11 157
John J. Manaloor United States 8 32 0.5× 31 0.8× 12 0.4× 75 3.8× 25 1.4× 18 165
M. Treilhaud France 6 99 1.6× 85 2.3× 22 0.8× 11 0.6× 59 3.3× 9 210

Countries citing papers authored by Michael Greiner

Since Specialization
Citations

This map shows the geographic impact of Michael Greiner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Greiner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Greiner more than expected).

Fields of papers citing papers by Michael Greiner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Greiner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Greiner. The network helps show where Michael Greiner may publish in the future.

Co-authorship network of co-authors of Michael Greiner

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Greiner. A scholar is included among the top collaborators of Michael Greiner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Greiner. Michael Greiner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Mancini, Stefano, Michael Greiner, Adrian Egli, & Oliver Nolte. (2025). In vitro susceptibility testing of vancomycin-resistant Enterococcus faecium to fosfomycin. Journal of Antimicrobial Chemotherapy. 80(6). 1742–1744.
2.
Greiner, Michael, A Anagnostopoulos, Daniel Pohl, Reinhard Zbinden, & Andrea Zbinden. (2021). A rare case of severe gastroenteritis caused by Aeromonas hydrophila after colectomy in a patient with anti-Hu syndrome: a case report. BMC Infectious Diseases. 21(1). 1097–1097. 9 indexed citations
3.
Reiner, Martin F., et al.. (2020). Für einmal nicht Coronavirus – Eine nicht alltägliche Ursache für Fieber und Hepatitis. Praxis. 109(14). 1150–1152.
4.
Mancini, Stefano, et al.. (2019). Detection of NDM-19, a novel variant of the New Delhi metallo-β-lactamase with increased carbapenemase activity under zinc-limited conditions, in Switzerland. Diagnostic Microbiology and Infectious Disease. 95(3). 114851–114851. 12 indexed citations
6.
Schreiber, Peter W., Verena Kufner, Stefan Schmutz, et al.. (2018). Metagenomic Virome Sequencing in Living Donor and Recipient Kidney Transplant Pairs Revealed JC Polyomavirus Transmission. Clinical Infectious Diseases. 69(6). 987–994. 12 indexed citations
7.
Schreiber, Peter W., Macé M. Schuurmans, Osvaldo Zagordi, et al.. (2017). Metagenomic sequencing complements routine diagnostics in identifying viral pathogens in lung transplant recipients with unknown etiology of respiratory infection. PLoS ONE. 12(5). e0177340–e0177340. 45 indexed citations
8.
Matter‐Walstra, Klazien, Michael Greiner, Alexia Cusini, et al.. (2015). Stringent adherence to a cytomegalovirus‐prevention protocol is associated with reduced overall costs in the first 6 months after kidney transplantation. Transplant Infectious Disease. 17(3). 342–349. 3 indexed citations
9.
Greiner, Michael, Alexia Cusini, Marc Schiesser, et al.. (2012). A stringent preemptive protocol reduces cytomegalovirus disease in the first 6 months after kidney transplantation. Infection. 40(6). 669–675. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026